56 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • Syndax Pharmaceuticals, Inc. SNDX shares jumped 68.6% to $19.40 after the company presented positive preclinical and initial clinical data for SNDX-5613, its potent, highly selective oral menin inhibitor, with the data suggesting the investigational asset can induce response in patients with genetically-defined acute leukemias.
  • RTI Surgical Holdings, Inc. RTIX gained 53% to $3.12. RTI Surgical reported second amendment to equity purchase agreement.
  • iBio, Inc. IBIO shares surged 48% to $1.3550 after the company provided an update on its COVID-19 vaccine manufacturing capacity. The company estimates it can make roughly 500 million doses of COVID-19 vaccines from its FastPharming facility.
  • Kura Oncology, Inc. KURA gained 32.4% to close at $13.80.
  • NGL Energy Partners LP NGL rose 26.4% to $4.11 after the partnership re-confirmed its fiscal year 2020 forecast and approved quarterly distributions.
  • Realogy Holdings Corp. RLGY surged 24% to close at $4.50.
  • SmileDirectClub, Inc. SDC gained 23.6% to close at $6.66 after the company announced it has been issued a patent for its SmileShop intellectual property from the U.S. Patent and Trademark Office.
  • Apergy Corporation APY shares rose 18.5% to $10.21 after reporting downbeat quarterly earnings.
  • Select Interior Concepts, Inc. SIC jumped 18% to $3.02.
  • GasLog Ltd. GLOG shares surged 17.8% to $4.23.
  • Aeglea BioTherapeutics, Inc. AGLE gained 17.3% to $6.51. Aeglea BioTherapeutics priced its 11.653 million share offering at $4.75 per share.
  • Dare Bioscience Inc DARE rose 17.1% to $1.2298 after Brookline Capital initiated coverage on the company's stock with a Buy rating and a $7.50 price target.
  • Document Security Systems, Inc. DSS shares rose 16.8% to $0.3490 after the company reported completion of required independent valuation, allowing it to proceed with the purchase of Impact BioMedical.
  • Spero Therapeutics, Inc. SPRO rose 16.6% to $11.89.
  • Simpson Manufacturing Co., Inc. SSD gained 16.6% to $73.80 following upbeat Q1 results.
  • Deciphera Pharmaceuticals, Inc. DCPH gained 16% to $56.11. Deciphera Pharmaceuticals is expected to release Q1 earnings on May 5.
  • InterDigital, Inc. IDCC rose 15.9% to $58.12 after the company signed a license agreement with Huawei.
  • Century Casinos, Inc. CNTY gained 15.6% to $3.99.
  • JELD-WEN Holding, Inc. JELD jumped 15% to $12.43.
  • Conn's, Inc. CONN shares rose 13.4% to $5.57.
  • Diebold Nixdorf, Incorporated DBD gained 12.6% to $4.78.
  • Quotient Limited QTNT shares rose 12.4% to $8.53 after the company announced "very strong" final study performance data for its SARS-CoV-2 antibody test.
  • Forward Pharma A/S FWP gained 12.1% to $7.46.
  • F5 Networks, Inc. FFIV rose 11.6% to $146.06 after the company reported upbeat results for its second quarter and issued strong outlook for the current quarter.
  • Harley-Davidson, Inc. HOG gained 11% to $21.01 after reporting strong quarterly results.
  • Cognex Corporation CGNX rose 10.7% to $55.10 after the company reported better-than-expected Q1 results.
  • AIM ImmunoTech Inc. AIM shares rose 10.4% to $2.10.
  • China SXT Pharmaceuticals, Inc. SXTC rose 10.3% to $0.4611.
  • Santander Consumer USA Holdings Inc SC jumped 8.4% to $14.60 after the company reported better-than-expected Q1 results.
  • JAKKS Pacific, Inc. JAKK shares rose 8.3% to $0.8558 after jumping 20% on Monday.
  • Hertz Global Holdings, Inc. HTZ rose 8% to $4.8350 after jumping 21% on Monday.
  • Party City Holdco Inc. PRTY gained 7.1% to $0.4713 after gaining 16% on Monday.
  • Keurig Dr Pepper Inc. KDP rose 6.1% to $27.44 after the company reported stronger-than-expected results for its first quarter.

 

Check out these big penny stock gainers and losers

Losers

  • Avinger, Inc. AVGR shares dropped 23.4% to $0.2620 after the company priced its $3.15 million underwritten public offering of common stock.
  • Blueprint Medicines Corporation BPMC fell 18.6% to $57.69 after the company's Phase 3 VOYAGER trial of Avapritinib did not meet its primary endpoint.
  • Chembio Diagnostics, Inc. CEMI dropped 18.2% to $10.53 after falling over 17% on Monday.
  • Naked Brand Group Limited NAKD fell 16.7% to $0.6501 after rising 61% on Monday.
  • Oxford Square Capital Corp. OXSQ shares tumbled 15.7% to $2.6550 following Q1 results.
  • FuelCell Energy, Inc. FCEL tumbled 15.6% to $2.0072.
  • CNX Resources Corporation CNX dipped 15.2% to $10.94. CNX Resources reported a private offering of $300.0 million of convertible senior notes. MKM Partners downgraded CNX Resources from Buy to Neutral.
  • DarioHealth Corp. DRIO shares declined 15.2% to $8.01.
  • Mesoblast Limited MESO fell 14.8% to $9.88.
  • Gaia, Inc. GAIA dropped 14.7% to $8.66 after the company reported downbeat Q1 results.
  • Yield10 Bioscience, Inc. YTEN fell 14.5% to $6.76. Yield10 Bioscience shares jumped 62% on Monday after the company obtained positive response from USDA-APHIS On regulatory status of its CRISPR Genome-edited C3007 trait in Camelina.
  • Harmonic Inc. HLIT fell 14% to $5.64 after the company reported weaker-than-expected Q1 results.
  • Sharps Compliance Corp. SMED dipped 13.7% to $6.58 after reporting downbeat Q3 results.
  • GameStop Corp. GME fell 12.2% to $5.11.
  • SilverBow Resources, Inc. SBOW dropped 12% to $4.41.
  • Cincinnati Financial Corporation CINF fell 12% to $72.15 following weak quarterly earnings.
  • Verastem, Inc. VSTM dropped 11% to $1.875.
  • Clearside Biomedical, Inc. CLSD shares dipped 10.9% to $1.9337. Clearside Biomedical revised NDA resubmission timeline and XIPERE commercial partnership with Bausch Health.
  • RedHill Biopharma Ltd. RDHL shares declined 10.7% to $7.68.
  • Aravive, Inc. ARAV fell 10.3% to $12.39.
  • NeuBase Therapeutics, Inc. NBSE declined 10.3% to $7.32 after the company announced a proposed public offering of common stock.
  • Vaxart, Inc. VXRT fell 9.5% to $3.312 after the company issued Q1 corporate update. The company said it had cash of $29.9 million as of March 31.
  • Amkor Technology, Inc. AMKR dipped 8.2% to $9.36. Amkor reported better-than-expected Q1 results, but issued Q2 earnings guidance below estimates.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!